1-5 of 5
Beata Kolodziej
Close
Sort by
Journal Articles

Differential in Vitro Drug Resistance Profile Between First and Second Relapsed Acute Lymphoblastic Leukemia and Acute Myeloblastic Leukemia in Children

Jan Styczynski, Beata Kurylo-Rafinska, Malgorzata Kubicka, Beata Kolodziej, Monika Pogorzala, Krzysztof Czyzewski, Robert Debski, Magdalena Wisniewska, Mariusz Wysocki, Michal Matysiak, Prof., MDPhD, Iwona Malinowska, Walentyna Balwierz, Prof MDPhD, Edyta Juraszewska, Jacek Wachowiak, Benigna Konatkowska, Mariola Woszczyk, MDPhD, Igor Olejnik, MD, Maryna Krawczuk-Rybak, Prof MDPhD, Marta Kuzmicz, Jerzy Kowalczyk, Prof MDPhD, Maria Jolanta Stefaniak, MD PhD, Wanda Badowska, Tomasz Szczepanski, Prof MD PhD, Renata Tomaszewska, Elzbieta Adamkiewicz-Drozynska, Lucyna Maciejka-Kemblowska, Grazyna Sobol, Agnieszka Mizia-Malarz, Joanna Szczepanek
Journal: Blood
Blood (2015) 126 (23): 3696.
https://doi.org/10.1182/blood.V126.23.3696.3696
Published: 2015
Journal Articles

Patterns of Individual Tumor Response Testing (ITRT) and Bone Marrow Minimal Residual Disease (MRD) On Day 15 of Therapy in Childhood Precursor-B-Lineage Acute Lymphoblastic Leukemia (ALL): MRD and Ex Vivo Drug Resistance Have Similar Predictive Value of Relapse.

Jan Styczynski, MD, PhD, Anna Jaworska-Posadzy, Malgorzata Kubicka, Robert Debski, MD, PhD, Beata Kurylo-Rafinska, Beata Kolodziej, Monika Pogorzala, MD, PhD, Magdalena Piatkowska, MD, Krzysztof Czyzewski, MD, PhD, Mariusz Wysocki, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2448.
https://doi.org/10.1182/blood.V120.21.2448.2448
Published: 2012
Journal Articles

Individualized Tumor Response Testing (ITRT) Profile Has a Prognostic Value in Childhood Acute Lymphoblastic Leukemia (ALL) and Acute Non-Lymphoblastic Leukemia (ANLL): The Multicenter Non-Interventional Long-Term Follow-up Study of Polish Pediatric Leukemia Study Group

Magdalena Piatkowska, MD, Jan Styczynski, MD, PhD, Beata Kolodziej, Beata Kurylo-Rafinska, Malgorzata Kubicka, Monika Pogorzala, MD, PhD, Krzysztof Czyzewski, MD, PhD, Robert Debski, MD, PhD, Michal Matysiak, MD, PhD, Iwona Malinowska, MD, PhD, Elzbieta Stanczak, MD, PhD, Walentyna Balwierz, MD, PhD, Edyta Juraszewska, MD, Jacek Wachowiak, Beningna Konatkowska, MD, PhD, Maria Wieczorek, MD, PhD, Igor Olejnik, MD, Maryna Krawczuk-Rybak, MD, PhD, Marta Kuzmicz, MD, Jerzy Kowalczyk, MD, PhD, Maria Jolanta Stefaniak, MD, PhD, Wanda Badowska, MD, PhD, Tomasz Szczepanski, Anna Balcerska, MD, PhD, Lucyna Maciejka-Kapuscinska, Grazyna Sobol, Agnieszka Mizia-Malarz, MD, Mariusz Wysocki, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1456.
https://doi.org/10.1182/blood.V118.21.1456.1456
Published: 2011
Journal Articles

Bortezomib Has No. Ex Vivo Activity in Chronic Myeloid Leukemia: Individual Tumor Response Testing Comparative Study in Pediatric and Adult Acute and Chronic Leukemia.

Krzysztof Czyzewski, Lidia Gil, Beata Kolodziej, Beata Rafinska, Krzysztof Lewandowski, Michal Gniot, Maria Lewandowska, Mieczyslaw Komarnicki, Mariusz Wysocki, Jan Styczynski
Journal: Blood
Blood (2009) 114 (22): 4257.
https://doi.org/10.1182/blood.V114.22.4257.4257
Published: 2009
Journal Articles

Prognostic Impact of Combined Ex Vivo Drug Resistance to Fludarabine, Treosulphan and Mitoxantrone in Childhood Acute Myeloid Leukemia.

Jan Styczynski, Mariusz Wysocki, Agnieszka Dluzniewska, Krzysztof Czyzewski, Robert Debski, Malgorzata Kubicka, Beata Rafinska, Beata Kolodziej, Edyta Juraszewska, Walentyna Balwierz, Igor Olejnik, Maria Wieczorek, Marta Kuzmicz, Maryna Krawczuk-Rybak, Jolanta Stefaniak, Jerzy Kowalczyk, Wanda Badowska, Tomasz Szczepanski, Danuta Sonta-Jakimczyk, Elzbieta Stanczak, Iwona Malinowska, Michal Matysiak, Benigna Konatkowska, Jacek Wachowiak, Lucyna Kapuscinska, Anna Balcerska
Journal: Blood
Blood (2005) 106 (11): 2780.
https://doi.org/10.1182/blood.V106.11.2780.2780
Published: 2005